These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 29208633)

  • 1. In Vivo Visualization of β-Cells by Targeting of GPR44.
    Eriksson O; Johnström P; Cselenyi Z; Jahan M; Selvaraju RK; Jensen-Waern M; Takano A; Sörhede Winzell M; Halldin C; Skrtic S; Korsgren O
    Diabetes; 2018 Feb; 67(2):182-192. PubMed ID: 29208633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the prostaglandin D
    Abadpour S; Tyrberg B; Schive SW; Huldt CW; Gennemark P; Ryberg E; Rydén-Bergsten T; Smith DM; Korsgren O; Skrtic S; Scholz H; Winzell MS
    Diabetologia; 2020 Jul; 63(7):1355-1367. PubMed ID: 32350565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GPR44 is a pancreatic protein restricted to the human beta cell.
    Hellström-Lindahl E; Danielsson A; Ponten F; Czernichow P; Korsgren O; Johansson L; Eriksson O
    Acta Diabetol; 2016 Jun; 53(3):413-21. PubMed ID: 26467464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The development of a GPR44 targeting radioligand [
    Jahan M; Johnström P; Selvaraju RK; Svedberg M; Winzell MS; Bernström J; Kingston L; Schou M; Jia Z; Skrtic S; Johansson L; Korsgren O; Farde L; Halldin C; Eriksson O
    EJNMMI Res; 2018 Dec; 8(1):113. PubMed ID: 30588560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the insulin secretory properties of the PGD2-GPR44/DP2 axis in vitro and in a randomized phase-1 trial of type 2 diabetes patients.
    Skrtic S; Tyrberg B; Broberg M; Ericsson H; Schnecke V; Kjaer M; Hompesch M; Andersson EM; Ryberg E; Aivazidis A; Wennberg Huldt C; Löfgren L; Morrow L; Parkinson J; Rydén-Bergsten T; Watkins E; Sörhede Winzell M
    PLoS One; 2018; 13(12):e0208998. PubMed ID: 30557325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GPR44 as a Target for Imaging Pancreatic Beta-Cell Mass.
    Eriksson O
    Curr Diab Rep; 2019 Jun; 19(8):49. PubMed ID: 31250117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [
    Carlbom L; Espes D; Lubberink M; Martinell M; Johansson L; Ahlström H; Carlsson PO; Korsgren O; Eriksson O
    Diabetes; 2017 May; 66(5):1286-1292. PubMed ID: 28246291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ramatroban-Based Analogues Containing Fluorine Group as Potential
    Huang LA; Huang KX; Tu J; Kandeel F; Li J
    Molecules; 2021 Mar; 26(5):. PubMed ID: 33800801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and preclinical evaluation of the CRTH2 antagonist [
    Eriksson J; Roy T; Sawadjoon S; Bachmann K; Sköld C; Larhed M; Weis J; Selvaraju RK; Korsgren O; Eriksson O; Odell LR
    Nucl Med Biol; 2019 Apr; 71():1-10. PubMed ID: 31082767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel pancreatic beta cell-specific proteins: antibody-based proteomics for identification of new biomarker candidates.
    Lindskog C; Korsgren O; Pontén F; Eriksson JW; Johansson L; Danielsson A
    J Proteomics; 2012 May; 75(9):2611-20. PubMed ID: 22465717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta Cell Imaging-From Pre-Clinical Validation to First in Man Testing.
    Demine S; Schulte ML; Territo PR; Eizirik DL
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33019671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A nanobody-based nuclear imaging tracer targeting dipeptidyl peptidase 6 to determine the mass of human beta cell grafts in mice.
    Demine S; Garcia Ribeiro R; Thevenet J; Marselli L; Marchetti P; Pattou F; Kerr-Conte J; Devoogdt N; Eizirik DL
    Diabetologia; 2020 Apr; 63(4):825-836. PubMed ID: 31873789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of PET Brain Radioligands for Imaging Pancreatic β-Cell Mass: Potential Utility of
    Bini J; Naganawa M; Nabulsi N; Huang Y; Ropchan J; Lim K; Najafzadeh S; Herold KC; Cline GW; Carson RE
    J Nucl Med; 2018 Aug; 59(8):1249-1254. PubMed ID: 29371405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PET Imaging of GPR44 by Antagonist [
    Cheung P; Zhang B; Puuvuori E; Estrada S; Amin MA; Ye S; Korsgren O; Odell LR; Eriksson J; Eriksson O
    Biomedicines; 2021 Apr; 9(4):. PubMed ID: 33923731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic imaging using an antibody fragment targeting the zinc transporter type 8: a direct comparison with radio-iodinated Exendin-4.
    Eriksson O; Korsgren O; Selvaraju RK; Mollaret M; de Boysson Y; Chimienti F; Altai M
    Acta Diabetol; 2018 Jan; 55(1):49-57. PubMed ID: 29064047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3D quantification of changes in pancreatic islets in mouse models of diabetes type I and II.
    Roostalu U; Lercke Skytte J; Gravesen Salinas C; Klein T; Vrang N; Jelsing J; Hecksher-Sørensen J
    Dis Model Mech; 2020 Dec; 13(12):. PubMed ID: 33158929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of β-Cell Identity Occurs in Type 2 Diabetes and Is Associated With Islet Amyloid Deposits.
    Spijker HS; Song H; Ellenbroek JH; Roefs MM; Engelse MA; Bos E; Koster AJ; Rabelink TJ; Hansen BC; Clark A; Carlotti F; de Koning EJ
    Diabetes; 2015 Aug; 64(8):2928-38. PubMed ID: 25918235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positron emission tomography ligand [11C]5-hydroxy-tryptophan can be used as a surrogate marker for the human endocrine pancreas.
    Eriksson O; Espes D; Selvaraju RK; Jansson E; Antoni G; Sörensen J; Lubberink M; Biglarnia AR; Eriksson JW; Sundin A; Ahlström H; Eriksson B; Johansson L; Carlsson PO; Korsgren O
    Diabetes; 2014 Oct; 63(10):3428-37. PubMed ID: 24848067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ectonucleoside Triphosphate Diphosphohydrolase-3 Antibody Targets Adult Human Pancreatic β Cells for In Vitro and In Vivo Analysis.
    Saunders DC; Brissova M; Phillips N; Shrestha S; Walker JT; Aramandla R; Poffenberger G; Flaherty DK; Weller KP; Pelletier J; Cooper T; Goff MT; Virostko J; Shostak A; Dean ED; Greiner DL; Shultz LD; Prasad N; Levy SE; Carnahan RH; Dai C; Sévigny J; Powers AC
    Cell Metab; 2019 Mar; 29(3):745-754.e4. PubMed ID: 30449685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative imaging of serotonergic biosynthesis and degradation in the endocrine pancreas.
    Eriksson O; Selvaraju RK; Johansson L; Eriksson JW; Sundin A; Antoni G; Sörensen J; Eriksson B; Korsgren O
    J Nucl Med; 2014 Mar; 55(3):460-5. PubMed ID: 24525204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.